Effect of Oral Administration of Dioctahedral Smectite and Cholestyramine with Phototherapy in the Treatment of Neonatal Hyperbilirubinemia.
- Author:
Jae Bong KWON
1
;
Myung Ho OH
;
Jay Gun SIM
;
Min Hee KIM
Author Information
1. Department of Pediatrics, College of Medicine, Kon Kuk University, Chungbuk, Korea.
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Cholestyramine;
Dioctahedral smectite;
Phototherapy;
Neonatal jaundice
- MeSH:
Administration, Oral*;
Aluminum Oxide;
Bile;
Bilirubin;
Cholestyramine Resin*;
Enterohepatic Circulation;
Hospitalization;
Humans;
Hyperbilirubinemia, Neonatal*;
Infant, Newborn;
Intestines;
Jaundice, Neonatal;
Phototherapy*;
Silicates
- From:Journal of the Korean Society of Neonatology
2000;7(1):39-44
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Dioctahedral smectite is an alumina silicate of phyllitic structure and absorbs bile acid in the intestine, forming a non-absorbable complex preventing enterohepatic circulation. The purpose of this study is to clarify the value of dioctahedral smectite and the adequate dosage, in combination with phototherapy, as well as to confirm whether it shortens the duration of hospitalization and to compare dioctahedral smectite with cholestyramine. METHODS: Total 45 full-term neonate with a total bilirubin level greater than 12 mg/dl were studied. The neonate were randomly divided into three groups : 1) Only phototherapy group (A) 2) 3.0 g/day dioctahedral smectite with phototherapy group (B) 3) 1.0 g/kg/day cholestyramine with phototherapy group (C). RESULTS: The mean serum bilirubin level of group B and C decreased significantly compared to group A at 48, 72 and 96 hours after the beginning of the study. The duration of phototherapy and hospitalization significantly decreased in group B and C. CONCLUSION: The data revealed that oral administration of dioctahedral smectite not only increased the efficacy of phototherapy, but also shortened the duration of phototherapy and can substitute for cholestyramine.
